Ting Zhao, MD

Ting Zhao, MD

264 Photos and videos

Tweets

Pinned Tweet

Ting Zhao, MD

@TingZhaoPathdoc

27 Aug 2025

🚨💡Excited to share our new publication @Histo_Journal Clinicopathologic, immunohistochemical and genomic characterization of urothelial carcinoma with myxoid and chordoid features @BWHPath @MGHPathology @MGBpathology doi.org/10.1111/his.15545 #GUpath #Molpath 🧬

9,816

Ting Zhao, MD

Ting Zhao, MD

@TingZhaoPathdoc

Jun 13

40s M with testicular swelling. Diagnosis? #PathX #PathTwitter @MGBpathology @MGHPathology

3,596

Ting Zhao, MD

Ting Zhao, MD

@TingZhaoPathdoc

Jun 13

Paratesticular biphasic mesothelioma harboring BRAF V600E mutation 🧬🧬 🚨Check out our case report: The First Report of BRAF V600E Mutation in Paratesticular Mesothelioma @IJSPjournal @MGBpathology ➡️journals.sagepub.com/doi/abs… #GUpath #MolPath

782

Association for Molecular Pathology

Ting Zhao, MD retweeted

Association for Molecular Pathology @AMPath

Jun 8

Presenting your work at #AMP2026 this November is an opportunity to gain feedback, build confidence and connect with experts. Abstract submissions and travel/poster award applications are due 6/30. Abstracts: ow.ly/fjLR50Z6UTc Awards: ow.ly/7J5A50Z6UTg

Quote from Prisca Santhanam A about receiving constructive feedback and support as an early-career researcher at the AMP annual meeting: “Presenting my poster on such
a prestigious platform was a memorable highlight.
I received constructive feedback from international peers and esteemed judges.
The supportive environment
for early-career researchers was palpable.”

ALT Quote from Prisca Santhanam A about receiving constructive feedback and support as an early-career researcher at the AMP annual meeting: “Presenting my poster on such a prestigious platform was a memorable highlight. I received constructive feedback from international peers and esteemed judges. The supportive environment for early-career researchers was palpable.”

346

Ting Zhao, MD

Ting Zhao, MD

@TingZhaoPathdoc

Jun 5

60s M, location and diagnosis? #PathX #PathTwitter @MGBpathology @MGHPathology @IntSocUropath

4,775

Ting Zhao, MD

Ting Zhao, MD

@TingZhaoPathdoc

Jun 6

Go to isupweb.net to view more cases from our group and others! (login is required) #GUpath #ISUPCOTM @IntSocUropath @katcollmd @LiangChengMD x.com/IntSocUropath/status/2…

International Society of Urological Pathology @IntSocUropath

Jun 1

Go to isupweb.net to see more of the case! #gupath #pathtwitter #ISUPCOTM Authors: Ting Zhao, MD, Kyle M. Devins, MD; Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA @TingZhaoPathdoc @md_kyle

792

Ting Zhao, MD

Ting Zhao, MD

@TingZhaoPathdoc

Jun 6

Replying to @MGBpathology @MGHPathology @IntSocUropath @md_kyle

Testicular neuroendocrine tumor (formerly testicular carcinoid tumor) #GUpath ➡️Rare, usually well differentiated ➡️Median age at diagnosis: 39 years (range, 10-83) ➡️Normal serum tumor markers (AFP, β-hCG, and LDH) ➡️Most (~77%) are primary and pure, as in the current case ➡️~17% are associated with teratoma; a small minority represent secondary involvement ➡️5-year disease-specific survival: ~84% ➡️Adverse prognostic factors: large tumor size, lower degree of differentiation, and the presence of carcinoid syndrome

475

Ting Zhao, MD

Ting Zhao, MD

@TingZhaoPathdoc

Jun 2

🎉 Congrats to Dr. Avash Das @avash22 for being the first winner of the 2026 #AMPtutorials (Social Media Challenge) hosted by @AMPath! 🏆 📢 Submit your entry now to win FREE registration to #AMP2026! amp.org/education/amp-molecu… ⏰ Submission deadline: August 31, 2026, at 2:59 PM Eastern. 🎯 TWO more winners will be announced in September! #MolecularPathology #PathX #PathTwitter

Social Media Challenge #AMPtutorials

We are delighted to introduce #AMPtutorials, an AMP Training and Education Committee social media challenge that we believe will increase our community's educational impact! Please see the following...

amp.org

Association for Molecular Pathology @AMPath

Jun 2

Congrats to @avash22, the first winner of our 2026 social media contest. His prize? Free registration to #AMP2026 in Seattle in November! 🥳 🧬 See his winning thread below. We'll name TWO more winners in September. Enter here by 8/31: amp.org/education/amp-molecu…. #AMPtutorials

1,208

USCAP

Ting Zhao, MD retweeted

USCAP @TheUSCAP

May 21

Join us June 4 for a discussion on physician burnout, workplace well-being, and strategies to help support long-term sustainability in pathology and laboratory medicine. Register now: buff.ly/SIXhsrQ

2,192

International Society of Urological Pathology

Ting Zhao, MD retweeted

International Society of Urological Pathology @IntSocUropath

Jun 1

2,302

Ting Zhao, MD

Ting Zhao, MD

@TingZhaoPathdoc

May 29

30s M, testicular mass. Diagnosis? #PathX #PathTwitter @MGBpathology @MGHPathology

5,069

Ting Zhao, MD

Ting Zhao, MD

@TingZhaoPathdoc

May 30

Postpubertal teratoma with exocrine pancreatic element #GUpath

1,193

Samson W. Fine, MD

Ting Zhao, MD retweeted

Samson W. Fine, MD @rovingatuscap

May 20

'Feelin' Groovy' - florid urothelial metaplasia in a prostate needle biopsy, mimicking basal cell hyperplasia and HGPIN at low magnification; at high magnification cytoplasmic vacuoles (upper R) & nuclear grooves (lower R) in the metaplastic cells aid in identification #gupath

3,228

Samson W. Fine, MD

Ting Zhao, MD retweeted

Samson W. Fine, MD @rovingatuscap

May 12

Beautiful angiomyolipoma/PECcoma of kidney displaying all 3 components, dystrophic vasculature (lower R), and perivascular epithelioid (PEC) cells radiating from the blood vessel (upper center) #gupath

1,502

Samson W. Fine, MD

Ting Zhao, MD retweeted

Samson W. Fine, MD @rovingatuscap

May 11

Striking abrupt transition in urothelium from normal/reactive changes (R) to flat urothelial carcinoma in situ (L), the latter marked by profound disorder of architecture and cytology #gupath

2,377

Ting Zhao, MD

Ting Zhao, MD

@TingZhaoPathdoc

May 8

50s M, testicular mass. Diagnosis? Gross photo in the chat. #PathTwitter #PathX @MGHPathology @MGBpathology

106

7,163

Ting Zhao, MD

Ting Zhao, MD

@TingZhaoPathdoc

May 9

✨Join GUPS @GU_Path_Society to read more Cases of the Month contributed by our team @PathDocBoston and many others! #GUpath 🔗Join GUPS here: gups.org/membership-account/…

475

Ting Zhao, MD

Ting Zhao, MD

@TingZhaoPathdoc

May 9

Replying to @MGHPathology @MGBpathology

Spermatocytic tumor with rhabdomyosarcomatous differentiation #GUpath ▶️Spermatocytic tumor component: small cells with dense nuclei and scant cytoplasm; intermediate-sized and giant cells with finely granular to filamentous (“spireme”) chromatin; CD117 , SALL4 , OCT3/4- ▶️Rhabdomyosarcoma component: large, pleomorphic, and frequently multinucleated polygonal and rhabdoid cells with eosinophilic cytoplasm; desmin ,MyoD1 ▶️Spermatocytic tumors are typically indolent ▶️Sarcomatous transformation (~6%)➡️ dramatic shift to highly aggressive behavior

646

Ting Zhao, MD

Ting Zhao, MD

@TingZhaoPathdoc

May 8

Replying to @MGHPathology @MGBpathology

903